Cosmetic cross-reference

103-11-7

CAS 103-11-7

103-11-7 (CAS 103-11-7) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
103-11-7
CAS Number
103-11-7
UNII
HR49R9S6XG
InChIKey
GOXQRTZXKQZDDN-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1574328
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
2-ETHYLHEXYL ACRYLATE
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Potency 6957.566666666667 nM 3 -
SOURCE NLM RxNorm 1 name row

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
2-ETHYLHEXYL ACRYLATE 1432294 SU MTHSPL
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 103-11-7 used for in pharmaceutical contexts?

103-11-7 (CAS 103-11-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 103-11-7?

No adverse-event association or SIDER side-effect rows are rendered for 103-11-7 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 103-11-7 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Ethylhexyl Acrylate (monomer) with EU status "prohibited".

What clinical phase is 103-11-7 in?

No phase 1-4 clinical development badge is rendered for 103-11-7 because the matched compound identifier rows do not contain a max-phase value.